Uterine clear-cell carcinoma
Uterine clear-cell carcinoma (UCCC) is a rare subtype of endometrial cancer, which is a type of cancer that begins in the uterus. It is characterized by the presence of clear cells, which are a type of cell that can be seen under a microscope. UCCC is considered to be a high-grade tumor, meaning it is likely to grow and spread more quickly than other types of endometrial cancer.
Epidemiology[edit | edit source]
UCCC is a rare form of endometrial cancer, accounting for less than 5% of all cases. It is more common in postmenopausal women, although it can occur at any age. The exact incidence of UCCC is unknown, as it is often grouped together with other types of endometrial cancer in epidemiological studies.
Pathogenesis[edit | edit source]
The exact cause of UCCC is unknown. However, it is thought to develop from the endometrial lining of the uterus, similar to other types of endometrial cancer. Some studies suggest that certain genetic mutations may play a role in the development of UCCC, although more research is needed in this area.
Clinical Presentation[edit | edit source]
Women with UCCC may experience a variety of symptoms, including abnormal vaginal bleeding, pelvic pain, and a palpable mass in the pelvic area. However, many women with UCCC do not have any symptoms until the disease has advanced.
Diagnosis[edit | edit source]
The diagnosis of UCCC is typically made through a combination of physical examination, imaging studies, and biopsy. The definitive diagnosis is made by examining tissue from the tumor under a microscope.
Treatment[edit | edit source]
The treatment of UCCC typically involves surgery to remove the uterus, fallopian tubes, and ovaries. This is often followed by radiation therapy or chemotherapy to kill any remaining cancer cells. The choice of treatment depends on the stage of the disease, the patient's overall health, and the patient's personal preferences.
Prognosis[edit | edit source]
The prognosis for women with UCCC is generally poor, due to the aggressive nature of the disease. However, early detection and treatment can improve the prognosis.
See Also[edit | edit source]
This gynecology related article is a stub. You can help WikiMD by expanding it.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD